MiniMed Group, Inc. Common Stock (MMED) Earnings Analysis

MiniMed Group, Inc. Common Stock (MMED) next reports earnings on 2026-09-01, consensus EPS 0.09 USD. Last quarter (2026-06-03) it missed with EPS -0.68 USD vs -0.14907 USD est (-356.2%). It has beaten estimates in 0/2 recent quarters (0%). Trailing P/E -14.85.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does MMED next report earnings?

Next earnings date2026-09-01
Consensus EPS estimate0.09 USD
Revenue estimate0.83B

MMED earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-06-03-0.68 USD-0.14907 USD-356.2%Miss
2026-04-17-0.095 USD0.1702 USD-155.8%Miss

Beat rate: 0/2 (0%) over reported quarters with consensus data.

MMED valuation and analyst view

Trailing P/E-14.85
Trailing EPS-1.90601 USD
Price / book1.21
Dividend yield0.00%
Market cap4.59B
Analyst consensusBuy (2 buy / 0 hold / 0 sell)
Avg price target19 USD

Related research pages

Frequently asked questions

When is MiniMed Group, Inc. Common Stock (MMED)'s next earnings date?

MiniMed Group, Inc. Common Stock is next scheduled to report on 2026-09-01, with a consensus EPS estimate of 0.09 USD and revenue estimate of 0.83B.

Did MMED beat earnings last quarter?

In its 2026-06-03 report, MMED posted EPS of -0.68 USD versus a -0.14907 USD estimate — a miss of 356.2%.

What is MMED's earnings track record?

Over the last 2 reported quarters with consensus data, MMED beat estimates 0 times (0%).

What is MMED's current P/E ratio and EPS?

MMED trades at a trailing P/E of -14.85 on trailing EPS of -1.9060052219321149 USD.

What do analysts rate MMED?

Analyst consensus is "Buy" across 2 ratings (0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 19 USD.